Table 2. Relationship between NET-associated markers and CAD risk factors.
| Variable | MPO | NE | dsDNA | |||
|---|---|---|---|---|---|---|
| r s | P-value | r s | P-value | r s | P-value | |
| BMI | 0.096 | 0.148 | 0.262 | <0.001 | 0.182 | <0.01 |
| Smoking | 0.017 | 0.794 | 0.073 | 0.273 | 0.101 | 0.129 |
| Hypertension | 0.258 | <0.001 | 0.350 | <0.001 | 0.356 | <0.001 |
| Glucose | 0.057 | 0.391 | 0.041 | 0.537 | 0.146 | <0.05 |
| CHO | 0.315 | <0.001 | 0.264 | <0.001 | 0.152 | <0.05 |
| TG | 0.186 | <0.01 | 0.127 | 0.054 | 0.187 | <0.01 |
| HDL-C | 0.136 | <0.05 | 0.061 | 0.357 | 0.033 | 0.616 |
| LDL-C | 0.249 | <0.001 | 0.193 | <0.01 | 0.149 | <0.05 |
| WBC | 0.210 | <0.01 | 0.157 | <0.05 | 0.413 | <0.001 |
| PMN | 0.206 | <0.01 | 0.145 | <0.05 | 0.364 | <0.001 |
Notes.
Nonparametric correlation analysis of variables associated with circulating NETs levels in all the study population.
- rs
- Spearman rho